---
title: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
date: '2024-05-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38785209/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240525190011&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Semaglutide reduced the risk of clinically important kidney
  outcomes and death from cardiovascular causes in patients with type 2 diabetes and
  chronic kidney disease. (Funded by Novo Nordisk; FLOW ClinicalTrials.gov number,
  ...'
disable_comments: true
---
CONCLUSIONS: Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease. (Funded by Novo Nordisk; FLOW ClinicalTrials.gov number, ...